Suppr超能文献

用于治疗胰腺癌的治疗性抗体。

Therapeutic antibodies for the treatment of pancreatic cancer.

作者信息

Chames Patrick, Kerfelec Brigitte, Baty Daniel

机构信息

INSERM U624, GDR2352, Marseille Cedex, France.

出版信息

ScientificWorldJournal. 2010 Jun 15;10:1107-20. doi: 10.1100/tsw.2010.103.

Abstract

Pancreatic cancer is a devastating disease with the worst mortality rate and an overall 5-year survival rate lower than 5%. In the U.S., this disease is the fourth leading cause of death and represents 6% of all cancer-related deaths. Gemcitabine, the current standard first-line treatment, offers marginal benefits to patients in terms of symptom control and prolongation of life. Since 1996, about 20 randomized phase III trials have been performed to improve the efficacy of gemcitabine, with little success regarding a significant improvement in survival outcomes. The need for novel therapeutic strategies, such as target therapy, is obvious. Monoclonal antibodies have finally come of age as therapeutics and several molecules are now approved for cancer therapies. This review aims to give a general view on the clinical results obtained so far by antibodies for the treatment of pancreatic cancer and describes the most promising avenues toward a significant improvement in the treatment of this frustrating disease.

摘要

胰腺癌是一种极具毁灭性的疾病,死亡率极高,总体5年生存率低于5%。在美国,这种疾病是第四大死因,占所有癌症相关死亡的6%。吉西他滨作为目前的标准一线治疗药物,在症状控制和延长生命方面给患者带来的益处有限。自1996年以来,已经进行了约20项随机III期试验以提高吉西他滨的疗效,但在显著改善生存结果方面收效甚微。显然需要新的治疗策略,如靶向治疗。单克隆抗体最终成为了治疗药物,目前有几种分子已被批准用于癌症治疗。本综述旨在对目前抗体治疗胰腺癌所取得的临床结果进行总体概述,并描述在显著改善这种令人沮丧的疾病治疗方面最有前景的途径。

相似文献

1
Therapeutic antibodies for the treatment of pancreatic cancer.
ScientificWorldJournal. 2010 Jun 15;10:1107-20. doi: 10.1100/tsw.2010.103.
2
Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Hum Vaccin Immunother. 2014;10(11):3354-68. doi: 10.4161/hv.34392.
3
Future strategies for targeted therapies and tailored patient management in pancreatic cancer.
Semin Oncol. 2007 Aug;34(4):354-64. doi: 10.1053/j.seminoncol.2007.05.002.
4
Novel targets for pancreatic cancer therapy.
Surg Oncol Clin N Am. 2010 Apr;19(2):419-29. doi: 10.1016/j.soc.2009.11.012.
5
Immunotherapy for pancreatic cancer: A long and hopeful journey.
Cancer Lett. 2018 Jul 1;425:143-151. doi: 10.1016/j.canlet.2018.03.040. Epub 2018 Mar 30.
6
Adjuvant therapy of pancreatic cancer using monoclonal antibodies and immune response modifiers.
Int J Pancreatol. 1997 Feb;21(1):43-52. doi: 10.1007/BF02785919.
7
Combinational therapy: new hope for pancreatic cancer?
Cancer Lett. 2012 Apr 28;317(2):127-35. doi: 10.1016/j.canlet.2011.11.029. Epub 2011 Dec 2.
8
Advanced stage pancreatic cancer: novel therapeutic options.
Expert Rev Clin Pharmacol. 2014 Jul;7(4):487-98. doi: 10.1586/17512433.2014.910451.
9
Monoclonal antibody therapies targeting pancreatic ductal adenocarcinoma.
Curr Drug Discov Technol. 2006 Dec;3(4):231-43. doi: 10.2174/157016306780368108.

引用本文的文献

1
Technological Advancements in Monoclonal Antibodies.
ScientificWorldJournal. 2021 Feb 10;2021:6663708. doi: 10.1155/2021/6663708. eCollection 2021.
2
3
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
Pancreatology. 2020 Jan;20(1):101-109. doi: 10.1016/j.pan.2019.11.011. Epub 2019 Nov 21.
4
MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma.
Expert Opin Ther Targets. 2017 Jul;21(7):657-669. doi: 10.1080/14728222.2017.1323880. Epub 2017 May 29.

本文引用的文献

2
Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma.
J Cell Mol Med. 2009 Sep;13(9B):4023-33. doi: 10.1111/j.1582-4934.2009.00723.x.
3
Catumaxomab: clinical development and future directions.
MAbs. 2010 Mar-Apr;2(2):129-36. doi: 10.4161/mabs.2.2.11221.
4
5
Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types.
Cancer Biol Ther. 2010 Apr 15;9(8):618-31. doi: 10.4161/cbt.9.8.11264. Epub 2010 Apr 20.
7
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?
MAbs. 2009 Nov-Dec;1(6):539-47. doi: 10.4161/mabs.1.6.10015.
8
Accomplishments in 2008 in the treatment of metastatic pancreatic cancer.
Gastrointest Cancer Res. 2009 Sep;3(5 Supplement 2):S43-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验